Concepedia

Matthew J. Reilley

MJ

21

Publications

1.1K

Citations

15

H-Index

2010

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Virginia

University of Virginia Health System

Dana-Farber Cancer Institute

University of California San Diego

Matthew J. Reilley is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, tumor immunity, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2024

21

Publications

21

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 275 citations · Full text

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Cancer Immunology Research · 2017 · 172 citations · Full text

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway

Todd Bartkowiak, Ashvin R. Jaiswal, Casey R. Ager et al. · Clinical Cancer Research · 2018 · 98 citations · Full text

Stoichiometry of STAT3 and Mitochondrial Proteins

Darci J. Phillips, Matthew J. Reilley, Angel Aponte et al. · Journal of Biological Chemistry · 2010 · 93 citations · Full text

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

Matthew J. Reilley, Brittany Morrow, Casey R. Ager et al. · Journal for ImmunoTherapy of Cancer · 2019 · 78 citations · Full text

, , +18

Rows per page

1–5 of 21